RAPT Therapeutics, Inc.·4

Apr 2, 9:08 PM ET

Robbins Wendye 4

4 · RAPT Therapeutics, Inc. · Filed Apr 2, 2025

Insider Transaction Report

Form 4
Period: 2025-03-31
Transactions
  • Award

    Director Stock Option (right to buy)

    2025-03-31$1.06/sh+49,432$52,50249,432 total
    Exercise: $1.22Exp: 2035-03-30Common Stock (49,432 underlying)
Footnotes (2)
  • [F1]The shares subject to the option vest in four equal quarterly installments on the last day of each fiscal quarter in 2025 with the first installment vesting on March 31, 2025, provided that the reporting person is in service as a director on the first day of the fiscal quarter of the applicable scheduled vesting date.
  • [F2]This option was issued to the reporting person pursuant to the Issuer's Amended and Restated Non-Employee Director Compensation Policy in lieu of an annual cash retainers for service on the Board of Directors and committees thereof in the aggregate amount of $52,500.

Documents

1 file
  • 4
    form4-04032025_010403.xmlPrimary